project id: TCGA-BRCA; case submitter id: TCGA-EW-A1IX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 48; days to birth: -17597; ethnicity: hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1960; age at diagnosis: 17597; ajcc pathologic m: MX; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1208.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8524/3; primary diagnosis: Infiltrating lobular mixed with other types of carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1030; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-EW-A1IX-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0;